Drug Type Antibody fusion proteins |
Synonyms- |
Target |
Action modulators |
Mechanism GDF modulators(progestagen associated endometrial protein modulators), activin receptor modulators(Activin receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | IND Application | Canada | 01 Jan 2026 | |
| Obesity | IND Application | Canada | 01 Jan 2026 |






